Covid-19 Solution

SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab)

The SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.

Product Features

Fast results  

Easy visual interpretation

Simple operation, no equipment required 

High accuracy   



Product Specification

  • PrincipleChromatographic Immunoassay
  • FormatCassette
  • SpecimenNasopharyngeal Swab
  • CertificateCE
  • Reading Time15 minutes
  • Pack20 T
  • Storage Temperature2-30°C
  • Shelf Life2 Years
  • Sensitivity97.6%(COVID-19) / 94.7%(Influenza A) / 93.0%(Influenza B)
  • Specificity99.7%(COVID-19) / 98.2%(Influenza A) / 97.7%(Influenza B)
  • Accuracy99.1%(COVID-19) / 97.7%(Influenza A) / 97.0%(Influenza B)

Ordering Information

Cat. No. Product Specimen Pack Cut-Off
ISIC-525 SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test Nasopharyngeal Swab 20 T -

Other products